Home    Back

I.v. immunoglobulins    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
151Rasmussen encephalitis1

151. Rasmussen encephalitis    [ 2 clinical trials,   4 drugs,   (DrugBank: 2 drugs),   6 drug target genes,   84 drug target pathways]
Searched query = "Rasmussen encephalitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00545493
(ClinicalTrials.gov)		November 200216/10/2007Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen EncephalitisEfficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis With Start of Treatment in the Acute Disease Stage. Prospective, Randomised, Open Parallel Group StudyRasmussen EncephalitisDrug: Tacrolimus;Drug: i.v. immunoglobulinsUniversity Hospital, BonnOctapharma;Astellas Pharma GmbHActive, not recruitingN/AN/ABoth16Phase 2;Phase 3Germany